Advocacy intelligence hub — real-time data for patient organizations
ProvayBlue: FDA approved
For treatment of pediatric and adult patients with acquired methemoglobinemia.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
ProvayBlue
Provepharm SAS
ProvayBlue
(methylene blue0.5%)Orphan drugProvepharm SAS
12.1 Mechanism of Action Methylene blue is a water soluble thiazine dye that promotes a non-enyzmatic redox conversion of metHb to hemoglobin. In situ...
Charles V Pollack, MD, MD
Hospital Quality Foundation
📍 ROSWELL, GA
Bruno Megarbane
Hôpital Lariboisière
Charles Morrow
Spartanburg Regional Healthcare System
Kristine Lombardozzi, MD
Spartanburg Regional Healthcare System
📍 SPARTANBURG, SC
Rusul Mahdi Abid
Al-Nassiryah Teaching Hospital
Brian Thurston, M.D
Spartanburg Regional Healthcare System
📍 SPARTANBURG, SC